Page last updated: 2024-10-21

zopolrestat and Diabetic Angiopathies

zopolrestat has been researched along with Diabetic Angiopathies in 1 studies

zopolrestat: structure given in first source

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research Excerpts

ExcerptRelevanceReference
"Methylguanidine was only approximately 7% as effective as aminoguanidine as an inhibitor of AGE formation from L-lysine and G6P; both compounds were poor inhibitors of AR."1.29Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. ( Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tilton, RG1
Chang, K1
Hasan, KS1
Smith, SR1
Petrash, JM1
Misko, TP1
Moore, WM1
Currie, MG1
Corbett, JA1
McDaniel, ML1

Other Studies

1 other study available for zopolrestat and Diabetic Angiopathies

ArticleYear
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
    Diabetes, 1993, Volume: 42, Issue:2

    Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; B

1993